• AT-406 (SM-406): IAP Antagonist for Cancer Research

  2026-08-14

  AT-406, also called SM-406, is an orally bioavailable antagonist of inhibitor of apoptosis proteins that targets XIAP, cIAP1, and cIAP2. Its research profile supports apoptosis pathway activation in cancer cells and chemotherapy-sensitization studies, while its product-specific evidence remains preclinical.

• Chicken GSDME Drives RNA Virus-Induced Pyroptosis

  2026-08-14

  The reference study identifies chicken GSDME as a principal pore-forming effector of RNA virus-induced pyroptosis, addressing a major gap created by the absence of GSDMD in chickens. Using infectious bursal disease virus, Poly(I:C), multiple RNA viruses, and genetic perturbation, the authors connect MDA5-driven signaling to caspase-3/7-dependent GSDME cleavage and viral release.

• Exo1: A Rigorous Framework for TEV Assays

  2026-08-13

  Exo1, or methyl 2-(4-fluorobenzamido)benzoate, offers a rapid way to interrogate ER-to-Golgi membrane traffic without reproducing every effect of Brefeldin A. This article presents a practical framework for connecting membrane trafficking inhibition to tumor extracellular vesicle assays while separating established evidence from translational hypotheses.

• Birinapant (TL32711): From IAP Biology to Translation

  2026-08-13

  Birinapant (TL32711) offers a mechanistically defined way to interrogate IAP-dependent apoptosis resistance. When read alongside new evidence linking MDM1, p53, and chemoradiotherapy response in colorectal cancer, it supports a biomarker-led framework for testing how apoptotic thresholds can be therapeutically reset—while clearly distinguishing evidence from hypothesis.

• HOXC8, Caspase-1, and NSCLC Pyroptosis

  2026-08-12

  The reference study identifies HOXC8 as a transcriptional suppressor of caspase-1 expression in non-small cell lung carcinoma (NSCLC). Its depletion increases caspase-1 abundance and triggers ASC-independent pyroptosis, revealing an epigenetic connection between a developmental transcription factor, inflammatory cell death, and lung tumorigenesis.

• From Hypoxia to ΔΨm: Translational Value of JC-1

  2026-08-12

  Hypoxia-activated Cyclin K degradation and phototherapy illustrate how combination therapies can create mitochondrial stress as a measurable translational endpoint. This article explains how the JC-1 Mitochondrial Membrane Potential Assay Kit can connect mechanistic apoptosis research with more rigorous preclinical decision-making.

• Rottlerin PKC Inhibitor: Workflow & Troubleshooting

  2026-08-11

  Rottlerin is a practical PKC inhibitor for connecting kinase signaling with cell proliferation, apoptosis, and virus-entry phenotypes. This guide translates its reported activity into controlled dose-response, viral-entry, and troubleshooting workflows while highlighting selectivity limits and assay-specific controls.

• Z-VAD-FMK: From Caspase Blockade to Plaque Biology

  2026-08-11

  A mechanistic and translational guide to using Z-VAD-FMK as a causal probe in apoptosis research, with atherosclerotic plaque biology as the framework. The article connects caspase inhibition with Bim-dependent macrophage apoptosis, experimental validation, assay design, and strategic interpretation.

• Demethyleneberberine: Mechanisms & Research Use

  2026-08-10

  Demethyleneberberine (DMB) is a berberine metabolite and natural isoquinoline alkaloid with anti-inflammatory, neuroprotective, anti-fibrotic, liver, gut, and NSCLC research applications. Its reported activity involves NF-κB, MAPK, AMPK, TLR4-mitochondria, NLRP3, and c-Myc/HIF-1α signaling, but most evidence remains preclinical.

• BPN-19186 in sEH–Nrf2 Osteoclast Research

  2026-08-09

  BPN-19186 supports a practical workflow linking soluble epoxide hydrolase, lipid mediators, Nrf2 signaling, and osteoclast differentiation. Its organic-solvent solubility and analytical documentation make it useful for paired enzyme inhibition studies and redox-focused cell assays, provided target engagement is independently confirmed.

• DOTAP for Ocular Gene Delivery Design

  2026-08-08

  Explore how 1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) can inform tissue-targeted nucleic acid delivery, using a glaucoma microneedle study to distinguish carrier chemistry from complete therapeutic platforms.

• Caspofungin: β-Glucan Inhibition in Candida Research

  2026-08-07

  Caspofungin is a lipopeptide antifungal drug that inhibits β-1,3-glucan synthase and weakens the fungal cell wall. Supplier-reported potency data and a cited murine Candida auris study support its use as a mechanistic comparator in antifungal therapeutics research.

• Shared Specificities of Inflammatory and Apoptotic Caspases

  2026-08-07

  This study introduces a tetrapeptide tool derived from the IL-18 sequence to probe substrate selectivity among human inflammatory and apoptotic initiator caspases. The findings reveal unexpected overlap in inhibitor and substrate specificity, including that VX-765, typically a caspase-1 inhibitor, also inhibits caspase-8, refining how researchers interpret caspase inhibition in inflammatory and cell death pathways.

• HOXC8 Suppresses Pyroptosis in NSCLC via Caspase-1 Regulatio

  2026-08-06

  The referenced study uncovers how HOXC8, a transcription factor, restricts pyroptotic cell death in non-small cell lung carcinoma (NSCLC) by repressing caspase-1 expression through HDAC1/2 recruitment. These findings clarify a non-canonical regulatory axis in tumor cell survival, suggesting new avenues for inflammation research and targeted apoptosis assays.

• Ibrexafungerp and Caspofungin: Tackling Drug-Resistant C. au

  2026-08-06

  Wiederhold et al. provide crucial evidence that ibrexafungerp, a novel triterpenoid antifungal, and caspofungin, a lipopeptide antifungal drug, are effective against fluconazole-resistant Candida auris in both in vitro and in vivo models. Their findings highlight the value of β-(1,3)-D-glucan biosynthesis inhibition for overcoming multidrug-resistant Candida infections, informing antifungal agent development and protocol design.

11659 records 1/778 page Next 12345 下5页 Last page